Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
are seeking an individual to join our data engineering team to deliver innovative data solutions that will transform scientific research and healthcare delivery. You will work as part of the health informatics
-
We are seeking to appoint a Postdoctoral Research Scientist in Molecular Biology to work on synthetic genome DNA assembly in the University of Oxford. This is an exciting opportunity arising from a
-
the responsible deployment of AI in clinical environments. To be considered, you must hold a Masters degree in engineering, mathematics or computational and have demonstrated experience in programming
-
About the Role We have an exciting new full-time opportunity for a Systems Administrator to join the department of Computer Science. Reporting to the Deputy IT Manager for Infrastructure, this role
-
180537 – Clinical Trial Manager Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Grade 7: Salary in the range of £38,674-£46,913 per annum (pro rata) This is a
-
Contract & job type: Full-time, Fixed-term for 18 months About us: At the Department of Physiology Anatomy & Genetics (DPAG) we undertake discovery science where we reassemble physiological
-
October 2023. The Research Programme Manager role will be based at the Institute of Biomedical Engineering in Headington and is fixed-term for up to 3 years in the first instance, with the possibility
-
learning, at the intersection of reinforcement learning, deep learning and computer vision, in order to train effective robotic agents in simulation. You should hold a relevant PhD/DPhil (or near completion
-
Internal Applicants Only The Translational Research Office (TRO) are looking to recruit a Translational Partnerships Manager in Global Health at Oxford, UK. The TRO sits within the Medical Sciences
-
, computational modelling, and in vivo physiology—to dissect cholesterol‑mediated modulation of key receptors like Glucagon receptor and GLP‑1R, with direct relevance to metabolic disease therapeutics. The Siebold